The aim of this study is to evaluate the results of treatment for hypopharyngeal cancer and indicate the future prospect of the treatment. Seventy-four patients with squamous cell carcinoma of the hypopharynx admitted to Miyagi Cancer Center from 1993 through 2000 are reviewed. Sixty-four patients received radical treatment, and 10 patients received palliative treatment or no treatment. The cancer was advanced (stages III and IV) in 82% of all the patients. The overall 5-year survival rate of all the patients was 38%. The overall 5-year survival rate of 64 patients received radical treatment was 43%. The ten patients who received palliative treatment or no treatment died of cancer within 16 months. Fifty-two out of the 74 patients underwent neck dissection for the neck lymph node involvement; forty of the 52 patients underwent ipsilateral neck dissection and 12 underwent bilateral neck dissection. Four out of the 40 patients, who underwent ipsilateral neck dissection alone, developed late contralateral regional recurrence but were successfully treated by contralateral neck dissection at the time of recurrence. Twenty-three out of 74 patients had multiple primary cancers synchronously or metachronously (31%). Cause of the death of six patients out of 74 patients was confirmed to be primary cancers other than hypopharyngeal cancer, as judged by physicians in other department or other hospitals. Most of the patients died due to distant metastasis from hypopharyngeal cancer or other primary cancers. We therefore conclude that contralateral elective neck dissection which is frequently chosen for the treatment of hypopharyngeal cancer surgery is unnecessary. Even if locoregional control is accomplished, distant metastasis or multiple primary cancers emerge and make prognosis poor. To improve the prognosis, we should develop some strategy against hypopharyngeal cancer for each patient. New strategies including chemoprevention and surgery against distant metasistasis are necessary.
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hypopharyngeal cancer; distant metastasis; multiple primary cancers; elective neck dissection sification of the International Union Against Cancer (UICC 1997) . pTN classification was based on the pathological findings. The T classification is classified by the expanse and the invasive region of the tumor. N0 is no It is generally accepted that the prognoses of the patients with hypopharyngeal cancer are poor. The main cause of poor prognosis has been high frequency of advanced cancer. Although radical surgery with subsequent reconstruction of the cervical esophagus by free jejunum transfer has become a relatively easy procedure for advanced cancer recently, the survival rate in such cases remains fairly poor. In hypopharyngeal cancer, there are various problematic issues such as the high frequency of distant metastasis, occurrence of multiple primary cancers (Schwartz et al. 1994; Ogawa et al. 1999) , choice of therapy such as radiation and surgery for the primary lesion, therapy for retropharyngeal lymph node (Hasegawa and Matsuura 1994) , and indication for contralateral elective neck dissection (Nishijima et al. 1991; Anderson et al. 1996; Lassaletta et al. 2002) . We thought that these many problems are compound and make survival rate decline. At our institution, in principal, the choice of radical therapies of the primary hypopharyngeal cancer lesion is radiation with chemotherapy or surgery, including partial pharyngectomy, and neck lymph node metastasis is treated by neck dissection with no contralateral elective neck dissection. Additional therapy is conducted in patients with multiple lymph nodes metastasis. Not all patients with hypopharyngeal cancer undergo radical treatment. Although there are many reports concerning each radical treatment (Pingree et al. 1987; Ho et al. 1993; Frank et al. 1994; Spector et al. 1995; Axon et al. 1997; Eckel et al. 2001; Godballe et al. 2002; Barzan et al. 2002) , general results of the treatment of hypopharyngeal cancer are unclear. Therefore we analyzed the results of treatment in 74 patients with hypopharyngeal cancer retrospectively to clarify each problem, and herein discuss appropriate treatment strategies for future prospect.
SUBJECTS AND METHODS
Seventy-four patients with squamous cell carcinoma of the hypopharynx who were admitted to our hospital for the first time from March 1993 through December 2000 were reviewed. We analyzed the treatment method, results of treatment and survival rate. The TNM and stage of each patient was classified according to the clas- regional lymph node metastasis. N1 is single ipsilateral lymph node metastasis, < 3 cm in greatest dimension. N2a is single ipsilateral lymph node, > 3 cm but not > 6 cm. N2b is multiple ipsilateral lymph nodes metastasis, none > 6 cm. N2c is bilateral or contralateral lymph nodes, none > 6 cm. N3 is a lymph node > 6 cm. Details of the patients' characteristics are listed in Table 1 . The patients consisted of 65 males and 9 females, with ages ranging from 31 to 81 years and a mean age of 63 years. The primary site was located on the right side of the hypopharyx in 34 patients, on the left side in 29 patients and in the center in 11 patients. The primary subgroup was located in the pyriform sinus (PS) of the hypopharynx in 50 patients, in the postcricoid (PC) region in 14 patients and on the posterior pharyngeal wall (PW) in 10 patients. Specimens of all patients were confirmed as squamous cell carcinoma of the hypopharynx by histological examination. Of these, 20 were welldifferentiated, 35 moderately differentiated, and 13 poorly differentiated; no definite confirmation of the grade of differentiation could be made in 6 patients. Sixty-four patients underwent radical treatment, and 10 patients underwent palliative treatment or no treatment. Fifty patients underwent surgical resection of their primary tumors, 23 patients received radiation for their primary tumors, 52 patients underwent neck dissection. Patients with tumors evaluated worse than pN2 were treated by postoperative irradiation. Chemotherapy was used for laryngeal preservation or additional treatment of advanced cancers. Details of the treatment are shown in Table 2 .
We used the criteria of multiple primary cancer proposed by Warren and Gates (1932) . 1) Each of tumors must present a definite picture of malignancy, 2) each must be distinct, and 3) the probability that one was a metastatic lesion from the other must be excluded. Multiple primary cancers were considered to be synchronous when found at the same time or within a six month period after diagnosis of hypopharyngeal cancer. Cancer found after six months was referred to as metachronous cancer (Gluckman and Crissman 1983) . Multiple primary cancers before incidence of hypopharyngeal cancer were evaluated based on anamneses and medical records. At initial treatment, except for locoregional evaluation of hypopharyngeal cancer, we routinely performed flexible gastroscopy, radiograph or CT of the chest, ultrasonography of the abdomen, and examination of occult blood in feces and urine. We performed colonoscopy, urological examination on demand. After treatment, follow-up visits were performed every 1-3 months. We routinely performed clinical examination of head and neck, including MRI or CT of head and neck, flexible nasopharyngolaryngoscopy and radiograph of the chest. We also performed CT of the chest, flexible gastroscopy, and other examination on demand. When the patients died of multiple primary cancers, we confirmed no recurrence of hypopharyngeal cancer based on medical records including laboratory data, imaging, and physical examination. Survival time was measured from the initiation of treatment. The cause-specific survival was calculated based on the event of patient's death of hypopharyngreal cancer. We calculated locoregional control rate based on the event of the patient's locoregional recurrence of hypopharyngeal cancer. Actual survival probabilities were calculated using the method of Kaplan-Meier, and com- I  3  3  2  3  1  0  II  10  2  2  7  9  0  III  19  17  17  10  10  0  IVA  35  26  28  16  24  3  IVB  5  0  1  5  5  0  IVC  2  2  2  1  1  0  Total  74  50  52  42  50  3 parisons of survival curves between all different subgroups were performed using the log-rank test. Informed consents of the patients were taken before treatment, and this study was approved by the ethics committee of Miyagi Cancer Center.
RESULTS
The overall 5-year survival rate of all patients was 38%, and the cause-specific survival rate was 48%. The overall 5-year survival rate and cause-specific survival rate of the patients who received radical treatment were 43% and 56%, respectively. The ten patients who received palliative treatment or no treatment died of cancer within 16 months. The overall survival rate at 5 years was 33% for patients with stage I cancer, 47% for those with stage II, 63% for those with stage III, 28% for those with stage IVA, and 0% for those with stage IVB or IVC (Fig. 1) . The survival rate of stage I patients was worse than expected. There were significant differences between the survival rate of the patients evaluated as stage I and that of the patients evaluated as stage IVB. There were also significant differences between the survival rate of the patients evaluated as II, III, or IVA and that of the patients evaluated as IVB or IVC.
The 5-year survival rate by T classification was 22% for patients with T1 tumors, 44% for T2, 41% for T3, and 19% for T4 (Fig. 2A) . The 5-year survival rate by N classification was 45% for patients with N0 tumors, 67% for patients with N1 tumors, 40% for patients with N2a tumors, 26% for patients with N2b tumors, 13% for patients with N2c tumors, and 0% for patients with N3 tumors (Fig. 2B ). The survival rate was Fig. 1 . Survival curves of the patients by stage classification. There were significant differences between the survival rate of the patients evaluated as stage I and that of the patients evaluated as stage IVB (p = 0.03), and between that of the patients evaluated as II, III and that of the patients evaluated as IVB, IVC (p < 0.01). There were also significant differences between the survival rate of the patients evaluated as stage IVA and that of the patients evaluated as IVC (p = 0.01), and between the patients evaluated as IVA and that of the patients evaluated as IVC (p < 0.01). All of the patients diagnosed as IVB and IVC died of cancer within 22 months. , stage I (n = 3) 5-year survival rate of 33%; , stage II (n = 10) 5-year survival rate of 47%;
, stage III (n = 19) 5-year survival rate of 63%; , stage IVA (n = 35) 5-year survival rate of 28%;
, stage IVB (n = 5) 5-year survival rate of 0%; , stage IVC (n = 2) 5-year survival rate of 0%. There was no significant difference among these 4 groups. , T1 (n = 9) 5-year survival rate of 22%; , T2 (n = 28) 5-year survival rate of 44%; , T3 (n = 29) 5-year survival rate of 41%; , T4 (n = 8) 4-year survival rate of 19%. B: Survival curves by N classification. The survival rate of the patients evaluated N0 and N1 was better than that of the patients evaluated as N2c and N3 (p < 0.01). Survival rate of the patients evaluated as N3 was worse than that of the patients evaluated as N2a and N2c (p = 0.02). The patients with N3 tumors died of cancer within 22 months.
, N0 (n = 21) 5-year survival rate of 45%; , N1 (n = 15) 5-year survival rate of 67%; , N2a (n = 5) 3-year survival rate of 40%;
, N2b (n = 20) 5-year survival rate of 26%; , N2c (n = 8) 5-year survival rate of 13%;
, N3 (n = 5) 5-year survival rate of 0%.
significantly related to N classification but not related to T classification. In the 64 patients who received radical treatment, disease recurred after the initial treatment in 33 patients between 3 and 70 months with a mean onset time of 14 months (Fig. 3A) . There was local recurrence in 8 patients. Of these, 6 patients had only local recurrence, one suffered from both local and distant metastasis, and one experienced local recurrence, regional lymph node re- currence and distant metastasis. Regional lymph node recurrence occurred in 11 patients, alone in 9 patients and together with distant metastasis in 1. Among 18 patients with distant metastasis, 15 patients showed no evidence for local and regional lymph node recurrence between 3 and 41 months with a mean onset time of 14 months (Fig. 3A) . Forty-five patients died between 1 and 98 months with a mean survival period of 21 months after initial treatment. Thirty-seven patients died of hypopharyngeal cancer. Six patients died of multiple primary cancers. One patient died of brain infarction and one other patient died of an unknown cause. The cause of the death of 11 patients was local recurrence of the disease, as judged by their clinical history. Of these, 3 patients died of local lesions alone, 5 died of local and regional lymph node lesions, 2 died of local lesions and distant metastasis, and 1 died of local, regional and distant metastasis. We also confirmed that the cause of the death was regional node recurrence of the disease. Of these, 4 patients died of regional lymph node lesions alone, and 5 died of regional and distant metastasis (Fig.  3B) . Distant metastasis occurred in 25 patients, and 17 of them died of distant metastasis and one is still alive despite metastasis. The metastatic lesions of these 25 patients were found in the lung (16 patients), the bone (2), the lung and bone (6), and the lung and liver (1).
Twenty-three out of 74 patients had multiple primary cancers (31%). Four patients had triple primary cancer lesions and 1 patient had quadruple primary cancer lesions. Table 3 shows clinical course and site distribution of multiple primary cancer lesions. The most frequent site of multiple primary cancers was the stomach. This was followed by the esophagus, larynx and colon in this order. Twelve out of 74 patients had multiple primary cancers before incidence of hypopharyngeal cancer (16%). Nine out of 74 patients had synchronous multiple primary cancer (12%). Five out of 74 patients had metachrounous multiple primary cancers after the incidentce of hypopharyngeal cancer (7%). Cause of the death of six patients was confirmed to be primary cancers other than hypopharyngeal cancer by physicians in other department or other hospitals.
We analyzed the survival rate and the locoregional control rate of the method of primary treatment. Fifty patients underwent primary resection and 21 patients underwent radiation for their primary tumors. There were no significant differences of the survival rate and locoregional control rate between these two groups. Results of treatment are shown in Table 4 . Thirty-seven patients underwent total pharyngolaryngectomy with cervical esophagectomy (TPLE), 6 patients underwent total laryngectomy with partial pharyngectomy (TL), and 7 patients underwent partial pharyngectomy (PP). The survival rate and locoregional control rate of the patients who received PP were significantly lower than those of the patients received TPLE.
Thirty-six patients received intravenous systemic chemotherapy, including conventional CDDP (cisplatin), 5FU-combined therapy, and weekly low-dose CDDP therapy. Six patients underwent intra-arterial CDDP chemotherapy aimed at laryngeal preservation. Thirty-two patients received no chemotherapy. There was no significant difference among these three groups.
Fifty-two patients out of 74 patients underwent neck dissection (ND); forty patients underwent ipsilateral ND alone and 12 patients were evaluated as N2c and underwent bilateral ND. Four of the patients who had undergone ipsilateral ND alone experienced contralateral regional recurrence between 6 and 18 months with a mean period of 12 months. These four patients were salvaged from hypopharyngeal cancer by contralateral ND, but 1 of them died of distant metastasis of gastric carcinoma 34 months after the initial treatment. Retropharyngeal node metastasis was found in 5 out of 74 patients (7%). All patients with retropharyngeal node metastasis died between 3 and 13 months with a mean period of 12 months after the initial treatment.
On initial treatment, by histological examination of dissected lymph nodes, we found 2 ipsilateral metastatic lymph nodes (4%) in the submandibular region, 32 (62%) such nodes in the upper jugular region, 18 (35%) such nodes in the mid-jugular region, 13 (25%) such nodes in the lower jugular region, 6 (12%) such nodes in the paratracheal region, and one (2%) such node in the supraclavicular region. Metastatic lymph nodes were mainly located at levels II, III and IV. In two patients, however, metastatic nodes were found at the medial inferior site of the submandibular gland. Contralateral lymph node metastasis was found in 10 patients histologically.
We analyzed the survival rate and the locoregional control rate based on the pN classification (Table 5 ). The 5-year survival rate of tumors diagnosed as pN0 was significantly higher than those diagnosed as pN2c. The survival rate of the patients evaluated as pN0 was higher than that of the patients who had 3 or more metastatic lymph nodes. There was no significant difference in the locoregional control rate among these groups.
DISCUSSION
This is a retrospective mono-institutional review of all patients diagnosed with hypopharyngeal cancer and admitted to Miyagi Cancer a Excluding 3 patients received no treatment. There was no significant difference between two groups. b Survival rate of the patients received PP was significantly worse than those of the patients received TLP (p = 0.02).
c Locoregional control rate of the patients who received PP was significantly worse than those of the patients who received TLP (p = 0.01).
d There was no significant difference among the three groups. 1  10  60  80  2  7  43  50  3  25  24   d   65 a There was no significant difference among the locoregional control rates of pN classification. b Survival rate of the patients evaluated as pN0 was better than that of the patients evaluated as pN2c (p = 0.03).
c There was no significant difference among the 5-year locoregional control rates of the 4 groups. d Survival rate of the patients evaluated the pN0 was better than that of the patients who had 3 or more metastatic lymph nodes (p = 0.04).
Center. The overall survival rate reported in the literature is approximately 10% -50%, with poorer results in advanced stages (Pingree et al. 1987; Ho et al. 1993; Spector et al. 1995; Wahlberg et al. 1998; Godballe et al. 2002; Barzan et al. 2002) . The overall 5-year survival rate of all patients in our study was 38%, and the cause-specific survival rate was 48%. The overall 5-year survival rate and cause-specific survival rate of the patients who received radical treatment including TPLE, following reconstruction by free jejunal transfer were 43% and 56%, respectively. The main failure was distant metastasis indicating that a new strategy, including chemotherapy and surgery, against distant metastasis is necessary to improve the survival rates.
Reports in the literature on multiple primary cancer of the hypopharynx are relatively few. The incidence of multiple primary cancers of the hypopharynx has been reported to be approximately 10% -20% in Japan (Ogawa et al. 1999) , and the estimated 5-year metachronous cancer incidence rate has been found to be 34.4% (Schwartz et al. 1994 ). In our study, 23 out of 74 patients had multiple primary cancers (31%). Six patients died of multiple primary cancers other than hypopharyngeal cancer. Nine out of 74 patients had synchronous multiple primary cancer (12%). Five out of 74 patients had metachrounous multiple primary cancers (7%). Although the incidence of multiple primary cancers without other previous cancer was relatively low at this time, it is increasing (Ogawa et al. 1999) , and thus long-term follow-up is needed. Regular examination including gastroscopy is important after initial treatment.
Treatment of primary tumors, including surgery and radiation, is decided based on the patient's condition and after consultation with the patient. In our results, the survival rate and locoregional control rate of the patients who received surgery tended to be higher than those of the patients who received radiation, but there was no significant difference between the two groups. In our results, the survival rate of the patients with stage I or T1 tumors was worse than that of the patients in other groups, as shown by the fact that the patients who received PP had a worse survival rate than those who were treated with other methods of primary resection. In 7 patients who underwent PP, there was local recurrence in 2 cases, regional recurrence in 2 cases, and distant metastasis in 1 case. Although some studies have reported that larynx-sparing surgical procedures do not adversely affect survival (Eckel et al. 2001; Barzan et al. 2002) , another study found that patients so treated had a worse prognosis (Czaja et al. 1997) . In the present study, results of PP for laryngeal preservation were unsatisfactory. Indications for PP and procedures including transoral resection or pharyngotomy are controversial (Zeitels et al. 1994; Steiner et al. 2001) . When a patient needs to undergo partial resection of a primary tumor, indication for PP must be carefully evaluated and additional therapies, including postoperative radiotherapy, are thought to be necessary.
The standard treatment of advanced hypopharyngeal cancer is surgery and postoperative radiotherapy (Vandenbrouck et al. 1977; Pingree et al. 1987; Frank et al. 1994; Axon et al. 1997; Hoffman et al. 1997; Eckel et al. 2001) , while chemoradiotherapy aimed at larynx-preservation has recently been reported (Kraus et al. 1994; Clayman et al. 1995; Lefebvre et al. 1996; Zelefsky et al. 1996; Samant et al. 1999) . Not all patients with hypopharyngeal cancer are treated by surgery for various reasons such as unresectable primary cancer or lymph node metastasis, patient refusal, and severe cardiopulmonary disorder (Eckel et al. 2001 ). In our study, although results of primary resection were better than those of radiation, there was no significant difference. If treatment results of surgery or radiotherapy are not significantly different, we need to have multiple strategies to treat hypopharyngeal cancer and explain general results and complications of each treatment to the patients.
In our study chemotherapy had no influence on survival and locoregional control rates. Concurrent low-dose chemotherapy and intraarterial chemotherapy were used for laryngeal preservation. It has been reported that concomitant or alternating chemotherapy in addition to ra-diotherapy results in slightly significant benefits and is useful for larynx preservation. The low significance of the resulting benefits, however, indicates that this procedure must be further investigated (Pignon et al. 2000) . The efficacy of intraarterial chemotherapy should be further elucidated by follow up and accumulation of cases in the future. At our institution, intravenous conventional chemotherapy as neoadjuvant chemotherapy or adjuvant chemotherapy in patients who receive radical resection needs to be reconsidered.
Elective contralateral neck dissection is controversial (Nishijima et al. 1991; Anderson et al. 1996; Lassaletta et al. 2002) . Four of our patients experienced contralateral regional recurrence, but they were salvaged by ND at the time of recurrence. Although we presently consider elective contralateral neck dissection to be unnecessary, its advisability shoud be reconsidered based on results of patient follow-up. It is well documented that regional lymph node metastasis of hypopharyngeal cancer is usually located at levels II, III and IV (Candela et al. 1990; Wenig and Applebaum 1991) . In our results, regional metastasis was mainly located at these levels in the patients who underwent initial neck dissection. Two patients who had a metastatic submandibular lymph node (level I), however, also experienced multiple lymph node metastases in other region including the retro-space of submandibular gland and the region near the hyoid bone. The histopathology of the one patient with metastasis to the submandibular lymph node was basaloid squamous cell carcinoma with a poor prognosis. Retropharyngeal node metastasis was found in 5 patients. All patients with retropharyngeal node metastasis died of cancer. Survival of the patients with retropharyngeal node metastasis was significantly worse than that of the patients with no retropharyngeal node metastasis (data not shown).
Generally, the N classification, pN classification and number of pathological metastatic lymph nodes have been shown to be important prognostic factors (Ono et al. 1985; Barzan et al. 2002) . In our results, the 5-year survival rate was significantly related to the pN classification and the number of pathological metastatic nodes.
In conclusion, the overall 5-year survival rate of our patients was 38%. The indication for and strategy of PP were decided carefully. Contralateral elective neck dissection is unnecessary. Regular examination to detect second primary malignancy is necessary. The main failure of hypopharyngeal cancer was distant metastasis. To improve general results, we should develop some strategy against hypopharyngeal cancer. New strategies including chemoprevention and surgery against distant metasistasis are necessary.
